Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -150,045 | -174,370 | N/A | -244,943 | -177,214 |
| Depreciation Amortization | 30,487 | 23,154 | N/A | 44,995 | 32,637 |
| Accounts receivable | 61,232 | 37,040 | N/A | -15,009 | -16,904 |
| Accounts payable and accrued liabilities | -1,196 | -1,925 | N/A | 5,054 | 2,623 |
| Other Working Capital | 25,969 | 11,882 | N/A | -22,099 | -5,301 |
| Other Operating Activity | 71,928 | 80,169 | 0 | 25,724 | 27,308 |
| Operating Cash Flow | $38,375 | $-24,050 | $N/A | $-206,278 | $-136,851 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 61,376 | 61,376 |
| PPE Investments | -11,170 | -4,075 | N/A | -6,154 | -4,326 |
| Investing Cash Flow | $-11,170 | $-4,075 | $N/A | $55,222 | $57,050 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,865 | 27,865 | N/A | 199,978 | 199,978 |
| Debt Repayment | -67 | -44 | N/A | -136 | -110 |
| Common Stock Issued | 542,504 | 541,353 | N/A | 1,258 | 603 |
| Common Stock Repurchased | -22 | -22 | N/A | N/A | N/A |
| Other Financing Activity | 91,310 | 113,535 | 0 | -1,034 | -492 |
| Financing Cash Flow | $661,590 | $682,687 | $N/A | $200,066 | $199,979 |
| Exchange Rate Effect | 159 | 97 | N/A | -3 | 13 |
| Beginning Cash Position | 68,028 | 68,028 | N/A | 60,007 | 60,007 |
| End Cash Position | 756,982 | 722,687 | N/A | 109,014 | 180,198 |
| Net Cash Flow | $688,954 | $654,659 | $N/A | $49,007 | $120,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,375 | -24,050 | N/A | -206,278 | -136,851 |
| Capital Expenditure | -11,170 | -4,075 | N/A | -6,154 | -4,326 |
| Free Cash Flow | 27,205 | -28,125 | 0 | -212,432 | -141,177 |